Introduction
Enzymes involved in the bacterial synthesis of diaminopimelate/lysine (DAP/Lys) are attractive targets for the development of bactericidal compounds, especially from bacteria that are deemed to be pathogenic. The Gram-negative bacterium Bartonella henselae is the causative agent of cat-scatch disease (CSD; Mazur-Melewska et al., 2015) . There are 25 species in the genus and 50% of the species have been implicated in CSD (Breitschwerdt & Kordick, 2000) . The reservoirs of B. henselae include, but are not limited to, cats, guinea pigs and rabbits; the majority of CSD infections are transmitted by cats based on a study in Poland that showed positive IgG antibodies for the bacterium in 50-90% of cats tested (Podsiadły et al., 2002) . The symptoms of CSD can include skin inflammation, fever, lymphadenopathy, various eye disorders, encephalitis and endocarditis (Mazur-Melewska et al., 2015) .
There are four variants of the diaminopimelate DAP/Lys pathway in bacteria. Using l-aspartate (Asp) as the starting molecule, all four variants share the common enzymatic steps for the synthesis of tetrahydrodipicolinate (THDP) from Asp . The synthesis of the penultimate compound meso-diaminopimelate (m-DAP) from THDP defines the uniqueness of the variants. In most bacteria, acetylated or succinylated (acyl) intermediates are used in the conversion of THDP to l,l-diaminopimelate (l,l-DAP) employing the enzymes DapD, DapC and DapE (Fig. 1) . In another variant, a few bacterial lineages employ the enzyme meso-diaminopimelate (m-DAP) dehydrogenase (Ddh), which catalyzes the synthesis of m-DAP from THDP in a single reaction, circumventing the acylase, aminotransferase, deacylase and epimerase enzymatic steps used in the acyl pathway ( Fig. 1) . A novel pathway was recently discovered in plants and subsequently in certain bacterial lineages that employs the enzyme l,l-DAP aminotransferase (DapL). DapL utilizes the acid glutamate as the amino donor and THDP as the amino acceptor to synthesize l,l-DAP in a single step circumventing the acylase, aminotransferase and deacylase reactions that are present in the acyl pathway (Hudson et al., , 2008 McCoy et al., 2006; Nachar et al., 2012) . The conversion of m-DAP to lysine by the enzyme m-DAP decarboxylase (LysA) is the final step in the pathway and is common to all four variants (Fig. 1) The reaction catalyzed by dihydrodipicolinate synthase (DapA) showing the condensation of l-aspartate 4-semialdehyde and pyruvate to form l-2,3dihydrodipicolinate. substrates pyruvate and l-aspartate 4-semialdehyde to synthesize l-2,3-dihydrodipicolinate ( Fig. 2) . Based on the fact that the gene is essential in bacteria and is a putative target for antibiotic development, there have been numerous studies regarding the structure of DapA from a number of pathogenic bacteria such as Escherichia coli, Mycobacterium tuberculosis, Neisseria meningitidis, Pseudomonas aeruginosa, Staphylococcus aureus and Bacteriodes thetaiotaomicron, which is an endosymbiont of the human gut (Dobson et al., 2005; Kefala et al., 2008; Devenish et al., 2009; Kaur et al., 2011; Burgess et al., 2008; Girish et al., 2008; Mank et al., 2015) . Although there has been a move to change the name of the enzyme to 4-hydroxytetrahydrodipicolinate synthase, we will use the more common enzyme name here (Bochaute et al., 2013) .
The de novo biosynthesis of DAP/Lys is absent in all animals, particularly humans, since their genomes do not contain the machinery necessary for the synthesis of DAP/Lys. As such, Lys is a deemed to be an essential amino acid and must be acquired through dietary means for protein synthesis. In addition, in bacteria, the penultimate intermediate m-DAP serves as a cross-linking amino acid in the synthesis of peptidoglycan (PG) in most Gram-negative bacteria, and Lys serves the same role in most Gram-positive bacteria (Hutton et al., 2007) . Therefore, since Lys and DAP are necessary for both PG and protein synthesis, the inhibition of enzymes associated with this pathway will lead to cell death via lysis as a result of the osmotic pressure from the lack of PG (Cox, 1996; Baizman et al., 2000) . The lack of protein synthesis would also lead to a bactericidal or bacteriostatic effect since Lys is one of the 20 ubiquitous proteogenic amino acids (Triassi et al., 2014) . Therefore, enzymes associated with the DAP/Lys pathway are attractive targets for the development of antibiotics, herbicides and algaecides. As such, the macromolecular structure of DapA from pathogenic bacteria affords the opportunity for the identification and or development of compounds that are deemed to be bactericidal. Here, we present the cloning, expression, purification, crystallization and X-ray diffraction analysis of dihydrodipicolinate synthase from the human pathogenic bacterium B. henselae strain Houston-1 (BhDapA), the causative agent of cat-scratch disease.
Materials and methods

Amplification and cloning of DapA from B. henselae
Cloning, expression and purification were conducted as part of the Seattle Structural Genomics Center for Infectious Disease (SSGCID) following standard protocols described previously (Myler et al., 2009; Stacy et al., 2011; Serbzhinskiy et al., 2015; Bryan et al., 2011; Choi et al., 2011) . The full-length research communications open reading frame (ORF) encoding amino acids 1-294 (UniProt Q6G468) was PCR-amplified from B. henselae strain Houston-1 genomic DNA (ATCC 49882D-5). The ORF was amplified using the following primer sequences: Bh-dapA-F, 5 0 -GGGTCCTGGTTCGATGCTCAAGGGAGCTGTGAC-CG-3 0 , and Bh-dapA-R, 5 0 -CTTGTTCGTGCTGTTTATT-ATTCTTTAAGCAAACCCGCATGGTA-3 0 . The ORF was cloned into the ligation-independent cloning (LIC) expression vector pAVA0421 encoding a cleavable 6ÂHis fusion tag followed by the human rhinovirus 3C protease-cleavage sequence (MAHHHHHHMGTLEAQTQGPGS) followed by the ORF (Aslanidis & de Jong, 1990) . The human rhinovirus 3C protease-cleavage site is between the glutamine and glycine residues that are underlined. Plasmid DNA was transformed into chemically competent E. coli BL21 (DE3) R3 Rosetta cells. The plasmid containing His-Bh-dapA was tested for expression and 2 l of culture were grown using autoinduction medium in a LEX Bioreactor (Epiphyte Three Inc.) as described previously (Studier, 2005; Choi et al., 2011) .
Protein production and purification
His-tagged BhDapA was purified in a four-step protocol consisting of an Ni 2+ -affinity chromatography (IMAC) step, cleavage of the N-terminal His tag with 3C protease, removal of the cleaved His tag by passage over a second Ni 2+ -affinity chromatography column and size-exclusion chromatography (SEC). All chromatographic steps were performed on an Ä KTApurifier 10 (GE Healthcare) using automated IMAC and SEC programs according to previously described procedures (Serbzhinskiy et al., 2015; Bryan et al., 2011) . Bacterial pellets were thawed into 200 ml lysis buffer consisting of 25 mM HEPES pH 7.0, 500 mM NaCl, 5% glycerol, 0.5% CHAPS, 30 mM imidazole, 10 mM MgCl 2 , 1 mM TCEP, 250 mg ml À1 AEBSF, 0.025% sodium azide and were lysed by sonication. Benzonase (20 ml, 25 units ml À1 ) was added and the crude lysate was mixed at room temperature for 45 min. The lysate was then clarified by centrifugation at 10 000 rev min À1 for 1 h using a Sorvall centrifuge (Thermo Scientific). The clarified supernatant was then passed over an Ni-NTA HisTrap FF 5 ml column (GE Healthcare) with a mobile phase consisting of loading buffer composed of 25 mM HEPES pH 7.0, 500 mM NaCl, 5% glycerol, 30 mM imidazole, 1 mM TCEP, 0.025% sodium azide. The column was washed with 20 column volumes (CV) of loading buffer and was eluted with loading buffer plus 250 mM imidazole in a linear gradient over 7 CV. His-MBP-3C protease was added to the eluted protein at a ratio of 1:50 to cleave the His tag. The protein was then transferred into a dialysis bag and dialyzed overnight at 4 C in 1 l of 3C dialysis buffer consisting of 25 mM HEPES pH 7.5, 200 mM NaCl, 5% glycerol, 1 mM TCEP. After overnight dialysis, the concentrations of imidazole and sodium chloride in the reaction mixture were adjusted to 30 and 500 mM, respectively, and the dialysate was passed over a second Ni 2+affinity column to remove His-MBP-3C protease, uncleaved protein and cleaved His tag. The cleaved protein was recovered in the flowthrough and concentrated prior to loading onto the final SEC column. A SEC column (Superdex 75, GE Healthcare) was equilibrated with running buffer composed of 20 mM HEPES pH 7, 0.3 M NaCl, 5% glycerol, 1 mM TCEP. The SEC chromatogram showed one predominant peak which was separated from a 70 kDa impurity (Fig. 3) . The retention time of the primary peak was used to estimate the molecular weight by comparison with known standards (data not shown). The estimated molecular weight was consistent with a tetrameric assembly in buffer solution. The peak fractions were collected and analyzed for the presence of the protein of interest using SDS-PAGE in a 4-20% gradient gel with Tris-MOPS running buffer for 40 min at 175 V. The peak fractions were pooled and concentrated to 25.2 mg ml À1 using an Amicon (Millipore) purification system (Fig. 3) . Aliquots of 100 ml were cryocooled in liquid nitrogen and stored at À80 C until use for crystallization. Reproducibility in Macromolecular Crystallography at http:// www.proteindiffraction.org.
Crystallization and data collection
Structure solution and refinement
The structure was solved by molecular replacement with Phaser (McCoy et al., 2007) from the CCP4 suite of programs using PDB entry 2rfg (B. S. Kang, M. H. Kim, G. H. Kim & K. J. Kim, unpublished work) as a search model. The structure was refined using iterative cycles of REFMAC5 (Murshudov et al., 2011) followed by manual rebuilding of the structure using Coot (Emsley et al., 2010) . The quality of all of the structures was checked using MolProbity (Chen et al., 2010) . Data-collection and datareduction and refinement statistics are shown in Tables 1 and 2, respectively. The structure was refined to a resolution of 2.1 Å . Unambiguous electron density was visible for the placement of 1,2-ethanediol, which was used as a cryoprotectant during cryocooling of the crystals (Fig. 4) . Structure figures were analyzed and prepared using PyMOL (v.1.5; Schrö dinger) and PISA (Krissinel & Henrick, 2007) . PISA analysis predicts a stable tetrameric assembly composed of four monomers, A, B, C and D, with a buried surface of 10 384 Å 2 . Stable dimers are predicted to be formed by molecules A and C and molecules B and D. The average buried surface of the AC and BD dimers was 3420 Å 2 ( Fig. 5 ; dimer interface), whereas the average buried surface of the AB and CD dimers was 2335 Å 2 ( Fig. 5 ; tetramer interface). Coordinates and structure factors have been deposited with the Protein Data Bank (PDB; http://www.rcsb.org) as entry 3si9.
Results and discussion
The DapA ortholog from B. henselae strain Houston-1 was successfully cloned, expressed and purified to homogeneity using a four-step purification protocol to a final concentration of 25.2 mg ml À1 . The purity of the enzyme was assessed by size-exclusion chromatography (SEC) and SDS-PAGE analysis (Fig. 3) and was suitable for crystallization trials.
Purified BhDapA was screened for crystallization in 96-well sitting-drop plates. The structure was subsequently refined to a resolution of 2.1 Å . The coordinates have been deposited in the PDB as entry 3si9. The three-dimensional structure of BhDapA is tetrameric in nature, consisting of four monomeric units that interact via a putative 'dimer interface' and a 'tetramer assembly' interface ( Fig. 5) . This is consistent with the structures of DapA orthologs from the bacteria E. coli Dobson et al., 2005; Mirwaldt et al., 1995) , Bacillus anthracis (Blagova et al., 2006) and Thermotoga maritima (Pearce et al., 2006) 
Figure 4
Electron density showing the placement of the 1,2-ethanediol solvent molecule. The molecule is highlighted by the yellow arrow.
Figure 5
Three-dimensional view of BhDapA (PDB entry 3si9) showing the tetrameric structure. The individual monomeric units are shown by the color scheme, with monomer A in red, monomer B in yellow, monomer C in green and monomer D in blue. The yellow arrow shows the ligand 1,2ethanediol. The dimeric and tetrameric assembly interfaces are highlighted with black arrows.
eukaryotic orthologs from the plant species Nicotiana sylvestris and Vitis vinifera (Atkinson et al., 2012) . Like the E. coli ortholog, each monomer of BhDapA consists of two domains in which each polypeptide possesses a (/) 8 -barrel structure connected to a predominantly -helical C-terminal domain (Mirwaldt et al., 1995; Fig. 6 ). The arrangement of the monomeric units forms a large cavity in the center where the two dyads connect (Fig. 6) . The structural features of the large cavity are conserved in bacterial orthologs but not in plant orthologs, where the dyads interact in a 'back-to-back' orientation that prevents cavity formation, as shown in the structures from N. sylvestris and V. vinifera (Atkinson et al., 2012) . A common feature of the bacterial enzyme is the presence of a conserved lysine residue in the active site. This lysine residue is involved in the catalytic mechanism of the enzyme through the formation of an enamine linkage via a Schiff base to the substrate (pyruvate) and the catalytic triad (Dobson et al., 2004) . The conserved lysine residue at position 166 in the structure (PDB entry 3si9) is shown in Fig. 6 . The structure of the DapA ortholog from Agrobacterium tumefaciens (AtDapA) has been solved (PDB entries 4i7w, 4i7v and 4i7u; S. C. Atkinson, C. Dogovski, R. C. J. Dobson & M. A. Perugini, unpublished work) with a pyruvate covalently linked to the conserved lysine residue involved in the Schiff-base reaction to facilitate substrate catalysis. As such, the active site is clearly defined in the A. tumefaciens structures. An overlay of BhDapA with the A. tumefaciens ortholog clearly shows the conserved lysine residue at position 166, highlighting the active site of BhDapA (Fig. 7) .
In summary, we present the cloning, purification, crystallization and X-ray diffraction analysis of DapA from the pathogenic bacterium B. henselae strain Houston-1. The structural information gathered from the characterization of Graphical representation of the secondary features of BhDapA (PDB entry 3si9). (a) depicts the various -helices and -barrels that comprise one of the four polypeptides. The black arrow highlights the methionine residue that is indicative of the translation start site and the black circle highlights the conserved lysine residue in the active site of the enzyme that is involved in catalysis at position 166. (b) Graphical key depicting the secondary-structural features of the enzyme.
DapA from this bacterium may be used to identify specific differences between bacterial orthologs of this diaminopimelate-and lysine-biosynthetic enzyme. This information has the potential to be useful in the design or identification of compounds that possess bactericidal activity.
